Aytu Biopharma (AYTU) Return on Capital Employed Growth (3y) (2018 - 2026)
Aytu Biopharma (AYTU) Return on Capital Employed Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | 3,135.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,135.00 |
| Dec 31, 2025 | 8,562.00 |
| Sep 30, 2025 | 10,387.00 |
| Jun 30, 2025 | 11,037.00 |
| Mar 31, 2025 | 9,545.00 |
| Dec 31, 2024 | 4,233.00 |
| Sep 30, 2024 | 3,799.00 |
| Jun 30, 2024 | 16,714.00 |
| Dec 31, 2023 | 704.00 |
| Sep 30, 2023 | -743.00 |
| Jun 30, 2023 | -684.00 |
| Mar 31, 2023 | -3,247.00 |
| Dec 31, 2022 | -5,011.00 |
| Sep 30, 2022 | -5,035.00 |
| Jun 30, 2022 | -6,910.00 |
| Mar 31, 2022 | -5,558.00 |
| Dec 31, 2021 | 2,083.00 |
| Sep 30, 2021 | 7,679.00 |
| Jun 30, 2021 | -6,507.00 |
| Dec 31, 2020 | 10,402.00 |